Accelmed is a healthcare technology investment firm that takes a private equity approach to investing in the sector, which is traditionally dominated by venture and early-stage growth firms. They focus on making control and growth investments in commercial-stage HealthTech companies. They actively engage with management teams to improve business operations, update product portfolios, and revamp commercial organizations, providing the support and resources needed for success. Accelmed aims to transform healthcare delivery by investing in medical devices, tools & diagnostics, digital health, and tech-enabled services. The firm invests in companies that are helping providers treat patients, advancing the study of medicine and biology, enhancing healthcare efficiency, and expanding patient access to care through value-based delivery.
Preferred startup development maturity for initial funding deployment.
Medical Devices, Tools & Diagnostics, Digital Health, Tech-Enabled Services
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...